OSE Immunotherapeutics
OSE.PA
HK$43.63
Share price
-2.39%
Change (1 day)
-13.60%
Change (1 year)
Categories
Earnings for OSE Immunotherapeutics (OSE.PA)
Earnings in 2024: HK$0.32 Billion
According to OSE Immunotherapeutics's latest financial reports the company's current earnings are HK$72.71 Million. In 2024 the company made an earning of HK$0.32 Billion, an increase over its 2023 earnings that were of -HK$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for OSE Immunotherapeutics from 2012 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2024 | HK$0.32 B | -261.47% |
| 2023 | -HK$0.21 Billion | 32.79% |
| 2022 | -HK$0.16 Billion | -0.83% |
| 2021 | -HK$0.16 Billion | -17.65% |
| 2020 | -HK$0.19 Billion | 1343.42% |
| 2019 | -HK$12.88 Million | -130.46% |
| 2018 | HK$42.26 M | -135.22% |
| 2017 | -HK$0.13 Billion | -182.62% |
| 2016 | HK$0.14 B | -403.67% |
| 2015 | -HK$47.84 Million | 76.85% |
| 2014 | -HK$27.05 Million | 897.97% |
| 2013 | -HK$2.72 Million | -81.82% |
| 2012 | -HK$14.92 Million |